Q1 Earnings Forecast for ABCL Issued By Bloom Burton
AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Research analysts at Bloom Burton issued their Q1 2025 earnings per share (EPS) estimates for AbCellera Biologics in a report issued on Monday, March 3rd. Bloom Burton analyst D. Martin forecasts that the company will post earnings of ($0.19) per share for the quarter. The consensus estimate […]
